The Asian University hosted a precision medicine forum on December 9, chaired by President Tsai Jinfa, and invited three American Harvard Medical School medical professors Alireza Haghighi, Patrick Ott, and Dr. David Allen Barbie to share the latest progress in the medical field. Dr. Alireza Haghighi emphasized that the new medical research direction is to emphasize the uniqueness of each case. Any single patient study can provide favorable information for patients with similar symptoms or gene mutations.
President Tsai Jinfa said that the Asian National University opened the first bioinformatics research institute in the country 17 years ago. At the same time, he and Zhang Jianguo, vice president of the affiliated hospital of China Medical University, jointly opened biomedical big data and precision medical research, with excellent results. Many well-known universities and research units at home and abroad have cooperated and have excellent performance in the fields of artificial intelligence, blockchain, financial technology, smart agriculture, food safety, 3D printing, fake news and other fields. Progress in the field of precision medicine.
Dr. Alireza Haghighi, a professor at Harvard Medical School, a physician at Brigham and Women ’s Hospital, and the president of the Medical and Scientific Progress Program, founder and director of GEnetics NEtwork (GENE-ME) in the Middle East, took the lead with “-Of-1 test) provides accurate clinical care and innovative therapy (n-of-many) message” the title pointed out that the key to precision medicine is to determine the underlying mechanism of the patient’s disease, so as to accurately provide treatment for the discovered target. Unlike traditional medical research, which requires a large number of patients with the same disease as the experimental object, the new medical research direction is to pay attention to the uniqueness of each case.